Mounjaro®
Starting from £179.99/mo
Start journey Learn moreItching at the injection site is one of the more common local reactions to Mounjaro, and it usually settles on its own within a day or two. The redness and itching happen because the skin responds to the needle puncture and to the medicine itself — a normal, low-level immune signal that most people notice early in treatment or after a dose increase. It is not a reason to stop treatment, but it is worth knowing when mild irritation crosses into something that needs a prescriber's attention. Mounjaro (tirzepatide) is a prescription-only medicine; a clinician assesses whether it is appropriate for you before any treatment begins. The NHS tirzepatide medicines page lists injection-site reactions among the expected side effects.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
After the pen clicks and you remove it from the skin, it is completely normal to feel a brief sting followed by mild itching at the puncture point. The tissue has been disturbed by a fine needle, and a small pocket of fluid is now sitting under the skin. Your immune system notices both events and responds with a local inflammatory signal, histamine release, a touch of swelling, and that familiar itch.
What you will typically see: a small pale or pink weal at the injection point, possibly some surrounding pinkness, and an urge to scratch that peaks within the first hour and then fades. A question our prescribers hear most weeks is whether this reaction means Mounjaro is not the right medicine, in almost every case, it simply means the skin is doing its job. The full guide to injection-site care covers what each type of reaction usually signals.
This kind of mild, short-lived itch is documented in clinical trial data for tirzepatide and appears more often at the start of treatment and after moving up to a new dose. It is not a sign that the medicine is harmful or that your body is rejecting it. If you are also wondering why your Mounjaro injection site hurts, that guide explains the difference between pain and itch and what each one typically means. Scratching, however, can introduce bacteria and slow healing, so the advice is to leave it alone or apply gentle, clean pressure with a finger for a minute after the injection.
If the itch is happening every week and lasting more than a day or two, the way you are injecting may be the main variable worth adjusting. Injecting into the same spot repeatedly causes cumulative skin trauma, the tissue never fully recovers between doses, so each new injection lands in already-sensitised skin. Rotating across different areas (abdomen, thigh, back of the upper arm) and moving at least 2 to 3 centimetres from the previous site gives each area a full week to settle.
Temperature also matters. Mounjaro should be kept refrigerated, but injecting cold medicine straight from the fridge can amplify the local reaction. Letting the pen sit at room temperature for a short while before use (without warming it in your hands or any heat source) can ease the initial sting and reduce the itch that follows. For exact guidance on how long this window is, the Mounjaro SmPC on the eMC gives the authorised storage detail your prescriber would refer you to.
Injecting too quickly can also push more fluid into one spot than the tissue absorbs comfortably. A slow, steady press of the button and a full ten-second hold before removing the pen lets the medicine disperse more evenly. Cleaning the skin with an alcohol swab before the injection is standard practice; if you do use one, letting it dry completely before the needle enters the skin prevents the alcohol from travelling into the puncture and irritating the tissue. Pre-injection swabs are available if you need them.
For mild itch that arrives on time and leaves within 24 to 48 hours, a cold clean cloth held against the site for a few minutes gives the most immediate relief. Some people find a non-perfumed moisturiser applied around (not directly over) the puncture point helps once the skin is intact. Oral antihistamines are sometimes used for recurring injection-site itch, but whether they are appropriate alongside your other medicines is something to check with your prescriber before starting them regularly.
The signs that move this beyond routine: itch that is spreading well beyond the injection point, swelling that is growing rather than reducing 24 hours after the injection, or a firm warm lump that stays for more than a few days. These can indicate a localised skin infection or a more significant immune response, and your prescriber will want to know. If you are seeing persistent redness alongside the itch, that is worth logging by date and site so you can describe the pattern clearly.
Separate from local reactions, be aware of the signs of a systemic allergic reaction: widespread hives, facial swelling, tightness in the throat or chest, or feeling faint. These require emergency help straight away. They are rare, but they are the reason the first few injections are worth doing somewhere you have easy access to help if needed. You can report any suspected side effect, including unexpected skin reactions, through the MHRA's Yellow Card scheme. Any reaction worth reporting is also worth discussing with your prescriber, your aftercare team at nume is available seven days a week for exactly this kind of concern.
Most people find injection-site itch becomes less noticeable after the first few weeks as the skin adapts to the weekly routine. If it remains a problem despite good technique (consistent rotation, correct temperature, slow administration) the conversation with your prescriber should cover whether an alternative injection site works better for you, and whether the pattern you are describing suggests anything that needs a clinical review.
It is also worth knowing that persistent itchiness at the injection site has been reported more commonly at certain dose levels, so if the itch arrived or worsened after a dose increase, flagging that timing gives your prescriber useful information. They may suggest staying at the current dose a little longer before the next step, or they may reassure you that the skin is simply recalibrating.
Mounjaro is a medicine that works over months, so a sustainable, comfortable injection routine matters. If you are at the beginning of your treatment journey and want to explore whether Mounjaro is clinically suitable for you, the free consultation at nume connects you with a GPhC-registered prescriber who reviews your case the same day. For a broader look at how treatment costs compare, the Mounjaro cost page sets out what a full private prescription typically covers. Understanding both sides (the clinical and the practical) makes the decision clearer.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.